TY -的T1 -技术治疗:使用虚拟互补和综合治疗患者在神经学(p1 - 1.虚拟)JF -神经学乔-神经学六世- 98 - 18补充SP - 510 AU -米娅Minen AU -尼尔商业盟盟史蒂芬•弗里德曼-玛雅坎首页贝尔盟Ananya Sahu AU - Kazi Maisha盟Quazi侯赛因AU -米娅Soviero盟Deepti Verma AU -莱斯利姚明盟Farng-Yang Foo盟Jaydeep Bhatt AU -劳拉Balcer盟-史蒂文Galetta AU -苏Thawani Y1 - 2022/05/03 UR - //www.ez-admanager.com/content/98/18_Supplement/510.abstract N2 -目的:考虑到减少之间的互访和增加teleneurology访问,我们试图确定病人增加了使用虚拟互补和综合治疗。背景:神经障碍患者可能会寻求治疗方法除了这些推荐的供应商。COVID-19流行前,大约一半的患者人群,寻求护理在神经病学互补和综合疗法(国旅)。首页设计/方法:通过检查两个单独的数据集,包括神经障碍患者群,我们评估患者使用的虚拟(非虚拟)国旅和决定是否有临床特征,预测其使用。组成的两个研究这份报告包括一个检查患者和提供者teleneurology访问的经历,和另一个评估COVID-19感染史的患者神经功能评价。首页结果:患者推迟治疗流感大流行期间non-COVID-19-related问题更有可能寻求中国国际旅行社。虚拟运动,虚拟心理疗法和放松冥想/智能手机应用程序是最常见的类型的虚拟国旅选择病人。在两个研究中,年龄是一个重要的人口因素与移动/虚拟CIT的使用有关。结论:从我们的调查数据表明,除了其他角色在teleneurology CIT-related技术可能用于治疗神经系统的条件。首页披露:Minen博士已经收到个人薪酬在500 - 4999美元的范围作为一个编辑,副主编,或疼痛医学期刊编辑顾问委员会成员。Minen博士的机构收到多丽丝·杜克的研究支持奖学金保留临床医师科学家。Minen博士的机构收到NIH的研究支持。Minen博士收到发现或技术知识产权利益有关卫生保健。 Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI . Dr. Minen has received personal compensation in the range of $0-$499 for serving as a consultant for ICER report with Institute for Comparative Effectiveness Research (ICER). Dr. Busis has received personal compensation for serving as an employee of American Academy of Neurology. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Mr. FRIEDMAN has nothing to disclose. Miss Campbell has nothing to disclose. Ms. Sahu has nothing to disclose. Ms. Maisha has nothing to disclose. Mr. Hossain has nothing to disclose. Miss Soviero has nothing to disclose. Ms. Verma has nothing to disclose. Ms. Yao has nothing to disclose. Dr. Foo has nothing to disclose. Dr. Bhatt has nothing to disclose. An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society. Dr. Galetta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Galetta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Thawani has nothing to disclose. ER -